Nasal Lacrimal Stent Market- Regional Analysis
On the basis of region, the nasal lacrimal stent market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the nasal lacrimal stent market during the forecast period, as key market players are focused on expanding their presence in the North America region. For instance, in Jan, 2019, FCI Ophthalmics entered an agreement with Carl Zeiss Canada Ltd. regarding the distribution of FCI Ophthalmics' range of lacrimal stents and tubes, which include Crawford & Ritleng, Mini Monoka & new Masterka (monocanicular stent), Bika & Nunchaku (Bicanicular stent) in Canada.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients